<DOC>
<DOCNO>
EP-0007277
</DOCNO>
<TEXT>
<DATE>
19800123
</DATE>
<IPC-CLASSIFICATIONS>
C07J-51/00 C07J-41/00 <main>C07J-31/00</main> C07J-9/00 C07H-15/14 C07H-15/00 C07J-31/00 A61K-39/39 
</IPC-CLASSIFICATIONS>
<TITLE>
new glycolipid compound useful as immunologic adjuvant and its preparation.
</TITLE>
<APPLICANT>
merck & co incus<sep>merck & co. inc.<sep>merck &amp; co., inc.126, east lincoln avenue p.o. box 2000rahway new jersey 07065-0900us<sep>merck & co. inc. <sep>
</APPLICANT>
<INVENTOR>
chabala john<sep>ponpipom mitree michael<sep>tsung-ying shen<sep>chabala, john<sep>ponpipom, mitree michael<sep>tsung-ying, shen<sep>chabala, john530 summit avenuewestfield, new jersey 07090us<sep>ponpipom, mitree michael431 brookview courtbranchburg, new jersey 08876us<sep>tsung-ying, shen935 minisink waywestfield, new jersey 07090us<sep>chabala, john<sep>ponpipom, mitree michael<sep>tsung-ying, shen<sep>chabala, john530 summit avenuewestfield, new jersey 07090us<sep>ponpipom, mitree michael431 brookview courtbranchburg, new jersey 08876us<sep>tsung-ying, shen935 minisink waywestfield, new jersey 07090us<sep>
</INVENTOR>
<ABSTRACT>
glycolipid compounds of the formulae    wherein r is    are useful immunologic adjuvants in vaccines.  
</ABSTRACT>
</TEXT>
</DOC>
